FDA Approves First Medical Device for ADHD

FDA Approves First Medical Device for ADHD On April 19, the Food & Drug Administration (FDA) gave the green light to the life sciences company NeuroSigma to market the first medical device designed to treat ADHD.

“This new device offers a safe, non-drug option for treatment of ADHD in pediatric patients through the use of mild nerve stimulation, a first of its kind,” Carlos Peña, PhD, the director of the Division of Neurological and Physical Medicine Devices in the FDA’s Center for Devices and Radiological Health, said in a statement.

Read more: https://bit.ly/2UTPAat

Source Healthline Media